Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology

Overview Zen Score Price Valuation Financials

Forecast Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
SNSE	SENSEI BIOTHERAPEUTICS INC	$25.57M	-44.00%	-38.60%	-49.41%	-43.30%	0.15	11.92	N/A	N/A	N/A
TRVI	TREVI THERAPEUTICS INC	$191.71M	-31.50%	-28.90%	-34.35%	-37.90%	0.08	15.03	N/A	N/A	N/A
DNTH	DIANTHUS THERAPEUTICS INC	$630.96M	-34.90%	-32.60%	-25.65%	-174.30%	0.06	18.43	100.00%	-1,541.20%	-1,541.22%
CRDF	CARDIFF ONCOLOGY INC	$181.84M	-50.20%	-44.30%	-58.21%	-60.20%	0.17	7.42	100.00%	-8,496.90%	-8,492.01%
NTBL	NOTABLE LABS LTD	$8.70M	-61.50%	-47.90%	-66.38%	695.20%	0.29	5.65	36.50%	-3,598.10%	-3,598.06%
MNKD	MANNKIND CORP	$1.14B	N/A	-3.40%	3.98%	2.70%	-2.93	3.59	68.50%	-6.00%	7.43%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$377.24M	-60.50%	-30.70%	-36.89%	-32.20%	1.14	4.66	55.60%	-132.30%	-124.18%
CDTX	CIDARA THERAPEUTICS INC	$57.61M	-218.00%	-32.70%	5,795.88%	155.20%	-9.16	0.90	97.60%	-35.90%	-35.19%
OCGN	OCUGEN INC	$329.38M	-103.00%	-77.80%	-132.91%	-409.40%	0.59	2.52	100.00%	-1,045.00%	-1,045.03%
URGN	UROGEN PHARMA LTD	$482.83M	N/A	-70.50%	-56.84%	-56.20%	-3.73	5.42	88.70%	-123.60%	-101.08%
PULM	PULMATRIX INC	$7.45M	-63.90%	-40.90%	-46.99%	-132.90%	0.89	5.33	100.00%	-193.50%	-193.49%
FOLD	AMICUS THERAPEUTICS INC	$3.04B	-119.50%	-20.40%	-16.38%	-16.80%	3.86	2.88	90.70%	-38.00%	-25.03%
RXRX	RECURSION PHARMACEUTICALS INC	$1.91B	-72.90%	-50.90%	-59.25%	-302.50%	0.41	4.70	4.50%	-736.00%	-745.10%
OCUL	OCULAR THERAPEUTIX INC	$705.24M	-288.90%	-48.50%	-31.96%	-75.00%	1.77	6.66	91.00%	-138.10%	-118.74%
PHAR	PHARMING GROUP NV	$657.65M	-5.10%	-2.40%	-3.12%	-3.50%	1.12	4.06	89.70%	-4.30%	-4.90%
LEXX	LEXARIA BIOSCIENCE CORP	$30.28M	-123.00%	-119.00%	-86.78%	-516.40%	0.03	66.29	95.40%	-1,410.70%	-1,409.68%
AADI	AADI BIOSCIENCE INC	$42.97M	-52.50%	-44.30%	-61.81%	-91.00%	0.26	4.72	88.50%	-270.00%	-269.09%
CANF	CAN-FITE BIOPHARMA LTD	$8.08M	-142.50%	-79.20%	-95.80%	-201.00%	0.60	4.91	100.00%	-1,027.50%	-1,027.46%
IMRN	IMMURON LTD	$15.03M	-20.00%	-18.10%	-21.93%	-143.60%	0.13	8.52	68.80%	-108.50%	-108.26%
HOOK	HOOKIPA PHARMA INC	$88.36M	-85.70%	-48.00%	-67.78%	-567.50%	0.80	3.50	100.00%	-405.30%	-401.88%
BLRX	BIOLINERX LTD	$44.55M	-280.20%	-99.20%	-176.72%	77,667.80%	3.83	1.53	23.10%	-1,262.80%	-1,217.60%
SILO	SILO PHARMA INC	$5.26M	-47.10%	-39.00%	-53.02%	-56.50%	0.25	9.90	91.90%	-5,132.60%	-5,125.81%
CRVO	CERVOMED INC	$146.98M	-18.30%	-15.50%	-29.44%	2,155.30%	0.35	3.84	100.00%	-30.40%	-30.40%
RGNX	REGENXBIO INC	$719.28M	-68.20%	-40.00%	-57.87%	-45.00%	0.84	2.57	58.80%	-292.00%	-284.55%
PSTX	POSEIDA THERAPEUTICS INC	$205.52M	-94.90%	-42.20%	-56.60%	-42.10%	1.64	3.18	100.00%	-190.80%	-177.20%
IPHA	INNATE PHARMA SA	$197.92M	-14.30%	-3.90%	-3.97%	-4.90%	2.55	3.73	100.00%	-12.30%	-9.30%
RPTX	REPARE THERAPEUTICS INC	$134.98M	-39.80%	-31.80%	-48.03%	-79.80%	0.20	6.24	100.00%	-183.40%	-201.79%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$1.94B	-24.10%	-5.70%	48.78%	48.90%	1.67	8.00	48.50%	-41.20%	236.37%
STOK	STOKE THERAPEUTICS INC	$574.63M	-56.90%	-41.60%	-58.02%	-348.70%	0.43	6.99	100.00%	-1,192.50%	-1,305.32%
TCRT	ALAUNOS THERAPEUTICS INC	$21.14M	-197.00%	-134.80%	-526.70%	-735.90%	0.31	4.22	100.00%	-702,800.00%	-664,380.00%
BRTX	BIORESTORATIVE THERAPIES INC	$8.46M	-114.70%	-107.20%	-124.83%	-141.20%	0.09	10.71	100.00%	-9,887.20%	-9,887.16%
MRNA	MODERNA INC	$41.25B	-29.90%	-22.50%	-25.58%	-25.80%	0.33	3.43	31.50%	-68.80%	-57.56%
CLLS	CELLECTIS SA	$139.29M	-84.10%	-35.80%	-26.34%	-21.80%	1.76	2.20	94.80%	-348.30%	-178.86%
ZNTL	ZENTALIS PHARMACEUTICALS INC	$784.82M	-63.90%	-52.00%	-60.70%	-68.10%	0.26	7.16	N/A	N/A	N/A
ANAB	ANAPTYSBIO INC	$562.02M	-119.40%	-32.60%	-39.43%	-37.70%	4.14	10.87	100.00%	-953.70%	-953.68%
LTRN	LANTERN PHARMA INC	$59.08M	-34.10%	-32.20%	-38.96%	-80.60%	0.07	16.18	N/A	N/A	N/A
PCSA	PROCESSA PHARMACEUTICALS INC	$6.14M	-141.40%	-122.20%	-219.96%	-2,795.10%	0.16	7.71	N/A	N/A	N/A
LENZ	LENZ THERAPEUTICS INC	$130.78M	-56.20%	-47.40%	-67.87%	-91.10%	0.03	39.20	N/A	N/A	N/A
PASG	PASSAGE BIO INC	$73.39M	-73.10%	-56.20%	-76.05%	-63.70%	0.35	7.22	N/A	N/A	N/A
CBUS	CIBUS INC	$382.25M	-86.10%	-49.20%	-47.65%	-156.60%	0.70	1.65	100.00%	-14,729.10%	-13,718.55%
KRON	KRONOS BIO INC	$60.10M	-58.80%	-45.00%	-59.75%	-57.50%	0.34	7.24	100.00%	-1,791.90%	-1,791.87%
VCEL	VERICEL CORP	$2.22B	-1.50%	-1.00%	-0.57%	-0.70%	0.57	4.50	68.60%	-1.60%	-0.90%
BNTC	BENITEC BIOPHARMA INC	$17.89M	-204.30%	-142.80%	-139.57%	903.40%	0.38	3.62	100.00%	-35,754.10%	-35,709.84%
IMVT	IMMUNOVANT INC	$3.95B	-61.10%	-55.30%	-35.93%	1,380.40%	0.05	22.14	N/A	N/A	N/A
IPSC	CENTURY THERAPEUTICS INC	$186.68M	-58.90%	-33.50%	-39.16%	-36.60%	0.95	9.92	100.00%	-6,115.10%	-6,006.80%
ATHA	ATHIRA PHARMA INC	$73.59M	-69.10%	-59.90%	-89.55%	-173.60%	0.23	5.37	N/A	N/A	N/A
ANNX	ANNEXON INC	$423.12M	-66.50%	-53.50%	-47.99%	-123.50%	0.19	14.72	N/A	N/A	N/A
IMRX	IMMUNEERING CORP	$43.05M	-52.50%	-47.60%	-56.44%	-202.20%	0.13	11.36	N/A	N/A	N/A
OMGA	OMEGA THERAPEUTICS INC	$125.20M	-110.40%	-48.30%	-54.87%	-52.60%	2.52	3.35	100.00%	-3,148.90%	-3,148.93%
CGEM	CULLINAN THERAPEUTICS INC	$1.09B	-32.10%	-30.40%	-36.68%	-44.40%	0.07	17.07	N/A	N/A	N/A
PCVX	VAXCYTE INC	$6.58B	-32.00%	-29.70%	-31.86%	-48.90%	0.14	7.54	N/A	N/A	N/A
XENE	XENON PHARMACEUTICALS INC	$3.06B	-25.20%	-24.00%	-19.49%	-28.10%	0.04	23.65	N/A	N/A	N/A
CLSD	CLEARSIDE BIOMEDICAL INC	$100.13M	N/A	-85.30%	-119.41%	-82.90%	-3.14	4.42	95.70%	-394.90%	-394.91%
AVIR	ATEA PHARMACEUTICALS INC	$312.25M	-23.10%	-22.00%	-23.99%	-31.40%	0.07	18.24	N/A	N/A	N/A
CGON	CG ONCOLOGY INC	$2.73B	N/A	-39.10%	-30.00%	-46.80%	-0.12	13.62	100.00%	-33,234.30%	-27,211.27%
ORIC	ORIC PHARMACEUTICALS INC	$543.72M	-42.70%	-38.60%	-43.49%	-52.70%	0.13	10.39	N/A	N/A	N/A
GLTO	GALECTO INC	$19.11M	-93.70%	-72.50%	-118.37%	-211.80%	0.18	6.31	N/A	N/A	N/A
XBIT	XBIOTECH INC	$239.65M	-10.80%	-10.50%	-11.03%	-45.00%	0.04	33.07	N/A	N/A	N/A
CRMD	CORMEDIX INC	$291.95M	-72.30%	-64.00%	-65.53%	-155.40%	0.17	6.97	N/A	N/A	N/A
VRCA	VERRICA PHARMACEUTICALS INC	$291.42M	-147.00%	-86.60%	-97.62%	-262.60%	3.13	4.55	85.40%	-1,307.50%	-1,230.15%
VXRT	VAXART INC	$123.44M	-108.50%	-73.30%	-105.25%	-117.40%	0.59	3.32	100.00%	-1,117.60%	-1,114.03%
KURA	KURA ONCOLOGY INC	$1.50B	-36.30%	-33.10%	-36.52%	-36.50%	0.13	12.26	N/A	N/A	N/A
BDTX	BLACK DIAMOND THERAPEUTICS INC	$304.62M	-76.40%	-56.20%	-59.34%	-78.70%	0.36	6.82	N/A	N/A	N/A
PMVP	PMV PHARMACEUTICALS INC	$90.03M	-30.30%	-27.30%	-28.96%	-38.80%	0.12	14.78	N/A	N/A	N/A
EXAI	EXSCIENTIA PLC	$506.58M	-36.20%	-26.20%	-36.13%	-59.80%	0.44	6.22	-36.50%	-726.90%	-801.94%
KTTA	PASITHEA THERAPEUTICS CORP	$7.55M	-50.50%	-46.60%	-67.97%	11,723.70%	0.12	6.34	N/A	N/A	N/A
STRO	SUTRO BIOPHARMA INC	$213.55M	-70.90%	-24.80%	-20.54%	-27.20%	2.15	4.50	100.00%	-69.50%	-50.36%
DOMH	DOMINARI HOLDINGS INC	$16.02M	-37.80%	-34.90%	-40.90%	-36.80%	0.09	17.51	100.00%	-1,122.20%	-1,122.22%
ARTL	ARTELO BIOSCIENCES INC	$4.33M	-61.70%	-58.10%	-79.04%	-108.80%	0.11	8.51	N/A	N/A	N/A
ACST	ACASTI PHARMA INC	$27.26M	-58.90%	-50.60%	-65.72%	-2,993.80%	0.18	15.19	N/A	N/A	N/A
CNTA	CENTESSA PHARMACEUTICALS PLC	$894.73M	-56.70%	-39.40%	-51.81%	-65.00%	0.53	8.00	100.00%	-2,204.70%	-2,425.73%
SNDX	SYNDAX PHARMACEUTICALS INC	$1.79B	-47.90%	-44.00%	-37.70%	-69.00%	0.11	10.00	N/A	N/A	N/A
MORF	MORPHIC HOLDING INC	$1.41B	-22.90%	-22.30%	-24.18%	-26.50%	0.03	38.17	N/A	N/A	N/A
LVTX	LAVA THERAPEUTICS NV	$71.77M	-68.50%	-35.70%	-51.48%	-148.50%	0.99	6.62	48.60%	-620.10%	-659.85%
VRAX	VIRAX BIOLABS GROUP LTD	$1.25M	-129.10%	-112.40%	-110.73%	-1,512.40%	0.15	7.59	11.40%	-8,730.70%	-8,710.56%
LGND	LIGAND PHARMACEUTICALS INC	$1.25B	N/A	N/A	N/A	N/A	0.12	14.15	N/A	N/A	N/A
LPTX	LEAP THERAPEUTICS INC	$83.20M	-133.20%	-90.90%	-135.37%	905.70%	0.21	5.65	N/A	N/A	N/A
NRIX	NURIX THERAPEUTICS INC	$607.50M	-67.10%	-43.60%	-64.27%	-65.30%	0.85	2.86	100.00%	-178.90%	-178.82%
NKTX	NKARTA INC	$339.49M	-38.10%	-28.10%	-33.05%	-26.60%	0.39	10.85	N/A	N/A	N/A
DYAI	DYADIC INTERNATIONAL INC	$43.17M	-81.60%	-65.70%	-113.88%	-342.90%	0.40	3.58	31.80%	-234.40%	-234.42%
ADMA	ADMA BIOLOGICS INC	$1.49B	-19.50%	-8.30%	-1.15%	-0.90%	1.44	5.16	34.40%	-10.90%	-1.24%
NXTC	NEXTCURE INC	$37.67M	-47.00%	-42.60%	-51.77%	-50.00%	0.12	16.38	N/A	N/A	N/A
ABEO	ABEONA THERAPEUTICS INC	$89.18M	-333.70%	-91.50%	-106.31%	-112.50%	3.32	4.15	100.00%	-1,548.20%	-1,536.29%
SABS	SAB BIOTHERAPEUTICS INC	$39.21M	-144.70%	-88.60%	-57.27%	-193.00%	0.47	5.45	100.00%	-1,884.50%	-1,870.42%
PRLD	PRELUDE THERAPEUTICS INC	$223.53M	-53.40%	-48.00%	-47.62%	-56.70%	0.17	10.79	N/A	N/A	N/A
EQ	EQUILLIUM INC	$60.29M	-51.80%	-22.60%	-53.42%	-181.50%	1.24	1.79	100.00%	-37.00%	-33.99%
ACET	ADICET BIO INC	$138.02M	-65.60%	-55.80%	-75.87%	-262.90%	0.22	8.41	N/A	N/A	N/A
QNCX	QUINCE THERAPEUTICS INC	$45.81M	-36.40%	-28.80%	-19.95%	-52.80%	0.97	8.09	N/A	N/A	N/A
GDTC	CYTOMED THERAPEUTICS LTD	$24.23M	-69.90%	-47.00%	-35.02%	-120.50%	0.10	14.08	N/A	N/A	N/A
VRNA	VERONA PHARMA PLC	$1.25B	-20.50%	-17.70%	-17.31%	-108.20%	0.24	33.33	N/A	N/A	N/A
BCRX	BIOCRYST PHARMACEUTICALS INC	$857.58M	N/A	-43.60%	-32.15%	-10.80%	-2.14	3.31	98.60%	-68.40%	-35.60%
ALDX	ALDEYRA THERAPEUTICS INC	$231.46M	-29.40%	-24.20%	-28.14%	-2,729.70%	0.24	6.64	N/A	N/A	N/A
VOR	VOR BIOPHARMA INC	$115.21M	-62.00%	-49.60%	-64.56%	-53.50%	0.31	9.04	N/A	N/A	N/A
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$73.84M	-47.40%	-40.80%	-58.41%	-164.60%	0.25	4.99	N/A	N/A	N/A
THRD	THIRD HARMONIC BIO INC	$440.94M	-11.20%	-10.80%	-11.32%	-433.80%	0.03	50.29	N/A	N/A	N/A
WVE	WAVE LIFE SCIENCES LTD	$569.84M	N/A	-23.70%	-65.74%	136.60%	5.74	1.26	100.00%	-50.80%	-51.36%
MACK	MERRIMACK PHARMACEUTICALS INC	$213.82M	-6.20%	-6.10%	-6.24%	-13.70%	0.02	43.50	N/A	N/A	N/A
EPIX	ESSA PHARMA INC	$268.97M	-17.40%	-17.00%	-18.30%	-23.40%	0.03	40.75	N/A	N/A	N/A
ENTX	ENTERA BIO LTD	$70.25M	-101.80%	-83.90%	-83.01%	2,881.30%	0.13	10.32	N/A	N/A	N/A
ERAS	ERASCA INC	$286.32M	-35.60%	-29.00%	-33.87%	-40.70%	0.25	12.26	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 75, which is 52 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.72% over the past year, underperforming other biotech stocks by -8 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 44.53% from Incyte's current stock price of $51.68.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best biotech stock with a Zen Score of 70, which is 47 points higher than the biotech industry average of 23. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -7.45% over the past year, overperforming other biotech stocks by 15 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.33% from Harmony Biosciences Holdings's current stock price of $29.32.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the third best biotech stock with a Zen Score of 66, which is 43 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Voyager Therapeutics has seen its stock return 2.42% over the past year, overperforming other biotech stocks by 25 percentage points.

Voyager Therapeutics has an average 1 year price target of $20.50, an upside of 169.03% from Voyager Therapeutics's current stock price of $7.62.

Voyager Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Voyager Therapeutics, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the biotech industry average of 15.1%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.38%, which is 42 percentage points higher than the biotech industry average of 15.1%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk A S (NYSE:NVO)

Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.08%, which is -14 percentage points lower than the biotech industry average of 15.1%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% eight times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.2% in the last day, and up 1.13% over the last week. Biodexa Pharmaceuticals was the among the top gainers in the biotechnology industry, gaining 79.31% yesterday.

Biodexa shares are trading higher after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Voyager Therapeutics has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Voyager Therapeutics's stock has gained 2.42% in the past year. It has overperformed other stocks in the biotech industry by 25 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -20.21% in the past year. It has overperformed other stocks in the biotech industry by 2 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -29.72% in the past year. It has underperformed other stocks in the biotech industry by -8 percentage points.

Are biotech stocks a good buy now?

49.23% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 91.76% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 14.88x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.